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Cytochrome P-450~ (P-450~), a cholesterol side-chain cleavage nzyme from bovine adrenocortical mitochondria, has 
been crystallized for the first time. Upon removal of glycerol from the solution of the native enzyme complexed with 
pyridoxal 5'-phosphate (PLP) by microdialysis against distilled water, reddish and planar crystals appeared. The crystals 
of native P-450~ were also obtained by the same procedure. We identified the crystals as the P-450~-PLP complex or 
native P-450~¢c by absorption spectroscopy and SDS-polyacrylamide g l electrophoresis, and characterized them under 
a polarization microscope. 
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1. INTRODUCTION 
Cytochrome P-450s¢¢ (P-450sc¢), a cholesterol 
side-chain cleavage nzyme, which is located in the 
inner mitochondrial membrane, catalyzes the con- 
version of cholesterol to pregnenolone [1,2], the 
initial rate-limiting reaction in the synthesis of 
various teroid hormones in the adrenal cortex. Of 
various P-450 isozymes, only P-450¢am, the soluble 
enzyme from the bacterium, Pseudomonas putida, 
has been crystallized using ammonium sulfate as a 
precipitant [3] and its high-resolution crystal struc- 
ture has been recently determined by Poulos et al. 
[4]. No animal isozymes, however, have been 
crystallized yet. 
Here we report the crystallization of P-450scc 
from the mammalian tissue, the bovine adrenal 
cortex, for the first time, which may be the first 
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step toward the X-ray crystallographic study of an 
animal P-450 isozyme. 
2. METHODS AND RESULTS 
2.1. Preparation of the enzyme 
P-450scc was purified from bovine adrenocorticai mitochon- 
dria by DEAE-cellulose, hydroxyapatite g l and adrenodoxin- 
Sepharose 4B column chromatographies as previously described 
by Tsubaki et al. [5]. The nonionic detergent, Emulgen 913, was 
removed by exhaustive washing of the enzyme on the affinity 
column with a buffer containing the ionic detergent, sodium 
cholate. Sodium cholate was removed by dialysis against 
20 mM potassium phosphate buffer (pH 7.4) containing 20% 
(v/v) glycerol and 0.1 mM EDTA (buffer A). All procedures 
for purification were performed in the presence of 20% (v/v) 
glycerol according to the method f Ichikawa and Yamano [6]. 
Protein concentration was determined by the biuret method. 
P-450 content was estimated by using 129.1 x 103 M- 1. cm - 1 as 
the molecular extinction coefficient at 448 nm in the absolute 
spectrum of the sodium dithionite-reduced CO complex [5]. 
The purified sample had a heme content of 19.0 nmol/mg pro- 
tein and showed a single protein staining band with a molecular 
mass of 51 kDa on SDS-polyacrylamide g l electrophoresis. 
P-450scc omplexed with cholesterol in buffer A was mixed 
with 10 mM PLP dissolved in buffer A to final concentrations 
of 10 mg protein/ml and 2 mM PLP. After the mixture was in- 
cubated at 25°C for 90 min, it was reduced with NaBH4 to at- 
tain the irreversible binding of PLP to the lysine residues of 
P-450scc and was then subjected to dialysis against buffer A. 
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Fig.1. Absorption spectra of the P-450sc¢-PLP complex. ( ) Oxidized form; ( - - - )  sodium dithionite-reduced CO form. (A) 
Absorption spectra of the P-450scc-PLP complex before crystallization. (B) Absorption spectra of the crystalline P-450scc-PLP 
complex. 
Fig.2. For legend see p.34. 
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Fig.2. (Contd). 
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Fig.2. (A) Crystals of the P-450~cc-PLP complex observed under a microscope in bright-field. Bar = 50/zm. (B) Crystals of native 
P-450~cc observed under a phase-contrast microscope. Bar = 50/Lm. (C) A type B crystal (the largest one) of the P-450scc-PLP complex. 
The picture was taken with light polarized parallel to the short axis of the crystal. Another large crystal crossed with the type B crystal 
is a type A crystal. Bar = 50/~m. (D) Same crystals as in C, but taken with light polarized parallel to the long axis of the type B crystal. 
Bar = 50/zm. 
The resulting sample showed a high-spin character in the ab- 
sorption spectrum due to binding of cholesterol to the substrate 
binding site. In addition, a new absorption band at 325 nm, 
characteristic of pyridoxal 5' -phosphate-e-lysine, wasobserved 
(fig.lA). There was no formation of P-420 form upon this 
treatment (fig.lA) and the modified enzyme became much 
stabler than native enzyme on spectroscopic criteria. (That is, 
during standing in the CO-reduced form at room temperature, 
the native enzyme became the P-420 form very soon, whereas 
the PLP-modified enzyme took a much longer time to undergo 
this transformation.) This sample was used initially for the 
crystallization experiment. 
2.2. Crystallization 
A microdialysis method was adopted. A droplet of the 
P-450scc-PLP complex (10 mg/ml) in buffer A was dialyzed at
4°C without stirring against 500 ml of distilled water, whose pH 
was previously adjusted to 5.5-6.0 with 1 mM NaOH. After 1 
week of dialysis, reddish and planar crystals were seen under a 
light microscope (fig.2A). 
We also crystallized native P-450scc by the same procedure ex- 
cept that pH of the dialysis medium was adjusted to 7.0-8.0 
(fig.2B). Reddish and thin column-shaped crystals were formed 
after 1 week of dialysis. Removal of glycerol from the enzyme 
solution during the dialysis was essential for the formation of 
the crystals in each case. 
2.3. Identification of crystals as P-450~c 
The crystals grown from the P-450scc-PLP complex were 
redissolved in buffer A and were analyzed byabsorption spec- 
troscopy and SDS-polyacrylamide gelelectrophoresis. The ab- 
sorption spectrum of the oxidized form showed a close 
similarity to that of the complex before the crystallization 
(fig.lB). The absorption spectrum of the CO-reduced form in- 
dicates a slight increase of P-420 form upon the crystallization. 
This may be due to a partial denaturation a d precipitation of
the enzyme during the dialysis. Upon SDS-polyacrylamide gel
electrophoresis, the crystalline complex co-migrated with the 
complex before the crystallization (fig.3). Similar analyses also 
established the identity of the crystals grown from the untreated 
enzyme as native P-450scc (not shown). 
2.4. Polarization microscope study 
Both the native and the PLP-complex crystals were sub- 
jected to analyses using a polarization microscope. We applied 
the plane-polarized light of various directions to a crystal and 
measured the optimal exposure time for taking a 
photomicrograph of a crystal by utilizing the built-in exposure 
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posure time for a crystal can be thought o reflect he angle 
dependence of the absorbance of the crystal against he plane- 
polarized light. 
As seen in fig.4, the P-450scc-PLP complex crystals could be 
classified into two types by the dependence of the exposure time 
on the direction of the incident polarized light. One type of 
crystal (type A crystal) required the longest optimal exposure 
time when the polarized light was parallel to the long or short 
axis of the crystal and the shortest time when 45 ° with the axis, 
while another type (type B crystal) required the longest ime 
when parallel to the short axis and the shortest ime when 
parallel to the long axis (fig.2C and D). We also found the ex- 
istence of two types of native P-450,¢~ crystals, which showed 
the same patterns of dependence of the optimal exposure time 
on the direction of the polarized light as the two types of the 
P-450,~c-PLP complex crystals, respectively. These results in- 
dicate that both of type A and B crystals are single crystals. 
Fig.3. SDS-polyacrylamide g lelectrophoretic analysis of the 
P-450,¢c-PLP complex. Lane M contains tandard molecular 
mass markers: phosphorylase b (94000), bovine serum albumin 
(67000), ovalbumin (43000), carbonic anhydrase (30000), 
trypsin inhibitor (20100) and ot-lactalbumin (14400). Lanes: l, 
20/~g untreated P-450~; 2, 20/zg the P-450scc-PLP complex 
before crystallization; 3, 20/zg the crystalline P-450,~c-PLP 
complex. 
meter of the camera system for automatic photomicrography 
(Nikon, UFX-2-35A). To be concrete, the optimal exposure 
time was measured with the measuring spot, which occupied 
1 °7o of the field of a microscope and was within a crystal at 
x 400 magnification. The angle dependence of the optimal ex- 
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Fig.4. Dependence of the optimal exposure time of a single type 
A ( - - - )  and a type B ( ) crystal on the direction of the 
polarized light. At an angle of 160 ° or 340 ° the plane-polarized 
light is parallel to the short axis of the type B crystal. At an 
angle of 90 °, 180 °, 270 ° or 360 ° the plane-polarized light is 
parallel to the long or short axis of the type A crystal. 
Measurements performed on five different single crystals of 
each type did not reveal differences in the periodicity of the 
curves, but there was a variation in the height of the curves. 
3. DISCUSSION 
P-450 isozymes have been found in bacteria 
[7,8], in yeast [9] and in mitochondria nd 
microsomes of animal tissues [10-14]. Of these 
isozymes, only P-450¢am, the bacterial isozyme 
soluble in aqueous media without detergent has 
been crystallized using ammonium sulfate as a 
precipitant. On the other hand, the other P-450 
isozymes are membrane proteins and use of the 
detergent is essential for their solubilization and 
purification. In the present study we crystallized 
P-450sc¢ from bovine adrenocortical mitochondria. 
This is the first successful crystallization of the 
P-450 isozyme located in the membrane. 
Since Ichikawa nd Yamano [6] found that addi- 
tion of glycerol prevented mammalian P-450 from 
converting to P-420, purification of mammalian 
P-450 isozymes has been generally performed in 
the presence of 20°70 (v/v) glycerol. In the present 
study, however, we found that removal of glycerol 
from the P-450scc solution resulted in the 
crystallization of the enzyme. For the crystalliza- 
tion of native P-450s¢¢, the optimum pH for the 
dialysis was 7.0-8.0; however, to crystallize the 
P-450~cc-PLP complex successfully, pH of the 
dialysis medium should be 5.5-6.0. This may be 
due to the decrease of the isoelectric point of 
P-450scc aused by the binding of PLP to the lysine 
residues of the enzyme. P-450scc omplexed with 
PLP was much stabler and crystallized more suc- 
cessfully than the native nzyme, probably because 
the covalent PLP modification of the enzyme in- 
creased binding affinity of cholesterol to the en- 
zyme (Tsubaki et al., unpublished). The 
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crystallization of the complex or the native en- 
zyme, however, occurs both in the presence and 
absence of substrate, cholesterol. 
In conclusion, the crystallization of P-450scc 
opens a new door to the study of relationship be- 
tween the function and the three-dimensional 
structure of membraneous P-450 isozymes. 
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